Nasal polyposis

Clinical and Experimental Allergy Reviews

Volumn 1, Issue 2, 2001, Pages 163-165

  Picado, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CORTICOSTEROID; PREDNISONE;

ARACHIDONIC ACID METABOLISM; CELL ACTIVITY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; HUMAN; NOSE POLYP; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034893901     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2001.00032.x     Document Type: Conference Paper

References (20)

1. The diagnosis and incidence of allergic fungal sinusitis
2. Prostaglandins leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa
3. Eicosanoids from biopsy of normal and polypous nasal mucosa
4. Prostaglandin endoperoxide H synthases-1 and -2
5. Regulation of cyclooxygenase-1 and-2 expression in human nasal mucosa. Effects of cytokines and dexamethasone
6. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
7. 4 excretion
8. Efficacy of topical corticosteroid powder for nasal polyps: A double-blind, placebo-controlled study of budesonide
9. Prophylactic treatment with flunisolide after polypectomy
10. Effect of Beconase spray on olfactory function in postnasal polypectomy patients: A prospective controlled study
11. Effect of fluticasone in severe polyposis
12. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized double-blind parallel, placebo-controlled study
13. Results of oral steroid treatment in nasal polyposis
14. Comparative studies of the effects of different glucocorticoids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps
15. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal-polyps
16. Videoendoscopic analysis of nasal steroid distribution
17. Benefits from adding the 5-lipoxygenase inhibitor Zileuton to conventional therapy in aspirin-intolerant asthmatics
18. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis
19. A new concept for treatment of sinonasal polypsosis